| |
How much is a company worth? |
| |
Click here to learn about our business
valuation services.
Click here to request a business valuation
specialist contact you.
|
|
|
|
| |
|
Welcome, and thank you for visiting Hempstead & Company. Since our founding as a financial consulting firm 30 years ago, we have provided our clients in a variety of industries with corporate valuations, fairness opinions, merger and acquisition advisory services and economic damages analysis. Our clients rely on our experience, expertise and informed judgment to provide financial analysis which is accurate and which can be defended against challenge. We have provided expert testimony on our work on numerous occasions in state and Federal courts.
We pride ourselves in hiring only the best and brightest. We have experience in a broad range of industries, including, but not limited to, consumer and industrial product manufacturing, health care, distribution, biotech, pharmaceuticals, insurance, financial services, media, retail, restaurants, technology and services.
What can Hempstead & Co. do for you?
- Business valuations for estate planning.
- Valuations for Employee Stock Ownership Plans (ESOPs).
- Valuations for shareholder buyouts.
- Valuations for shareholder dissenter’s rights.
- Valuations for matrimonial matters.
- Valuations for financial reporting.
- Purchase price allocations for mergers.
- Goodwill impairment studies.
- Fairness opinions.
- Stock option valuations.
- IRS Sec. 409A valuations.
- Valuations for bankruptcy matters.
- Economic damages analysis.
- Merger & acquisition advisory services.
You can rely on our experience, developed through over 3,000 valuation assignments. If you have a question, please contact us. We look forward to the opportunity to be of service.
OUR RECENT E-LETTERS
"SEQUOIA SLIDESHOW" IS THE TALK OF THE LIFE SCIENCES VENTURE SUMMIT
About two dozen venture capitalists gathered in New York last week (October 30) at the 2008 Life Sciences and Healthcare Venture Summit to discuss the current state of the market for venture capital for life science and healthcare companies. Exhibit A to the discussion was a provocative and much-talked-about Power Point presentation that Sequoia Capital has recently sent to its clients and portfolio companies. Entitled "R. I. P. Good Times," the presentation paints a gloomy view of the outlook for venture financing for early-stage companies, and provides advice to the management of such companies on how to survive what Sequoia foresees as a prolonged rough period in the capital markets........ [More]
IS THE HOLMAN FLP VALUATION DECISION A WIN FOR THE IRS?
The U. S. Tax Court, in its recent decision, Holman v. Commissioner, 130 T. C. No. 12 (May 27, 2008), may have given the IRS a new weapon to use in its long-running campaign to dilute the effectiveness of the family limited partnership as an estate planning tool........ [More]
MULTI-LEVEL DISCOUNTS ALLOWED IN GIFT TAX VALUATION
In a recent Tax Court gift tax valuation decision, the court (Swift) permitted the taxpayer to apply a 30% valuation discount for lack of control and marketability to a partnership interest held within a family limited partnership, and a successive 17.47% discount for lack of control and 22% discount for lack of marketability to gifted limited partnership interests in the FLP........ [More]
NEW FAIRNESS OPINION RULING ADDRESSES CONFLICTS
The SEC has approved a new rule addressing conflicts of interest by firms providing fairness opinions in connection with change of control transactions. Rule 2290, originally drafted by the NASD (now FINRA), took effect December 8, 2007........ [More]
|
807
Haddon Avenue Haddonfield,
NJ 08033 